Riversedge Advisors, Llc
Source: SEC Form 13F · as of Mar 2026Riversedge Advisors, Llc holds 17 biotech & pharma companies tracked by BioSniper, totaling $8.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
17
Total value held
$8.9M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 6,006 | $1.5M |
| BMYBRISTOL MYERS SQUIBB CO | 16,987 | $1.0M |
| ABBVAbbVie Inc. | 4,601 | $1.0M |
| MRKMerck & Co., Inc. | 6,525 | $785K |
| LLYELI LILLY & Co | 823 | $757K |
| AZNASTRAZENECA PLC | 2,763 | $545K |
| NVSNovartis AG | 3,458 | $528K |
| ABTABBOTT LABORATORIES | 4,453 | $457K |
| PMPhilip Morris International Inc | 2,249 | $372K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,211 | $328K |
| BIIBBIOGEN INC. | 1,529 | $280K |
| REGNREGENERON PHARMACEUTICALS, INC. | 359 | $277K |
| GMOptec International, Inc. | 3,310 | $247K |
| MEDPMedpace Holdings Inc. | 427 | $205K |
| NBIXNEUROCRINE BIOSCIENCES INC | 1,551 | $204K |
| GSKGSK plc American Depositary Shares (Each representing two Ordinary Shares) | 3,669 | $202K |
| GILDGILEAD SCIENCES, INC. | 1,449 | $202K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.